APLI — Appili Therapeutics Inc.

Price Chart

12 months daily · TSX:APLI

Insider Transactions

90-day window · no filings

No insider transactions in the last 90 days.

Score Breakdown

Signal Analyst · $29/mo

Component	Points	Max	Detail
Conviction (unique buyers) ✓ FREE PREVIEW	0	30	No insider activity
Buy/sell ratio		20	0% buys (0B / 0S)
Dollar value		25	No open-market buys
Lobbying activity		15	1 regs
Contract wins		10	None
Insider track record		10	No track record data
Private placements		8	None
Confluence bonus		10	None
Cluster timing (velocity)		10	No coordinated buying cluster detected
Buy/sell reversal pattern		8	No buy/sell reversal pattern
Total	10	100

Unlock Component Detail — CAD $29/mo

Lobbying Registrations

OCL active · 1 registrations

Effective	Registrant	Subject Matter	Institutions	Status

Unlock 1 Registration — CAD $29/mo

Government Contract Wins

90-day window · none found

No government contract wins in the last 90 days. Analyst plan →

Private Placements

12 months · Signal Analyst · $29/mo

Private placement history, deal size, and lock-up expiry tracking. Analyst plan →

Indigenous Consultation

no records on file

No Indigenous consultation records on file for APLI.

SEDAR+ Filings

official filing registry

Form55 monitors SEDAR+ filing alerts and newswire announcements for Technical Reports and material changes. Search SEDAR+ →

Short Interest

CIRO · Sep 30, 2026

Shares short

13,852

Net change

+53 (+0.4%)

History

Sep 30: 13,852

Sep 15: 13,799

Aug 31: 8,660

Aug 15: 9,885

Jul 31: 16,841

Jul 15: 19,813

Aggregate short position from CIRO's Consolidated Short Position Report (published twice monthly).

Clinical Trials

ClinicalTrials.gov · 3 trials

Phase	Status	Trial	Updated
P3	Completed	The Prevent Severe COVID-19 (PRESECO) Study	Mar 2024
P1	Completed	Bioavailability of ATI-1501 With Taste Test Sub Study	Jan 2019
P2	Terminated	Control of COVID-19 Outbreaks in Long Term Care	Feb 2023

Trials where this company is the lead sponsor (ClinicalTrials.gov). Phase advances, completions and terminations are material catalysts for clinical-stage companies — not investment advice.

Boardroom Connections

2 insiders also active elsewhere

Insider	Other boards	Also an insider at
gowd, prakash	1	RX (70)
Bloom, Brian Matthew	1	WOLF (10)

People who file as insiders here and at other TSX/TSXV companies (number in brackets = that company's Confluence Score). A well-connected insider taking a seat at a new junior can be an early tell. Matched by name across SEDI filings; funds and 10%+ holders excluded.

Government Grants & Funding

3 federal awards · $1.2M total

Program / Agreement	Department	Amount	Start
— Contribution	National Research Council Canada	$760K	Jan 2016
— Contribution	National Research Council Canada	$359K	Jan 2016
— Contribution	National Research Council Canada	$50K	Aug 2015

Federal grants & contributions disclosed by the Government of Canada (Proactive Disclosure), matched to this issuer by legal name. Government funding can be a pre-revenue validation and capital signal. Display-only context, not a Confluence Score input.